Neuroendocrine prostate cancer is an aggressive variant of prostate cancer that may arise
de novo or develop from pre-existing prostate adenocarcinoma as a mechanism of treatment …

Homologous recombination (HR) deficiency is associated with DNA rearrangements and
cytogenetic aberrations 1 . Paradoxically, the types of DNA rearrangements that are specifically …

The molecular characteristics of metastatic upper tract urothelial carcinoma (UTUC) are not
well understood, and there is a lack of knowledge regarding the genomic and transcriptomic …

Background Characterization of circulating tumor DNA (ctDNA) has been integrated into clinical
practice. Although labs have standardized validation procedures to develop single locus …

The availability of fresh frozen (FF) tissue is a barrier for implementing RNA sequencing (RNA-seq)
in the clinic. The majority of clinical samples are stored as formalin-fixed, paraffin-…

Background Frequency of clinically relevant mutations in solid tumors by targeted and whole-exome
sequencing is ∼30%. Transcriptome analysis complements detection of actionable …

Sarcomatoid urothelial carcinoma (SUC) is a rare subtype of urothelial carcinoma (UC) that
typically presents at an advanced stage compared to more common variants of UC. Locally …

The molecular characterization of male breast cancer (MaBC) has received limited attention
in research, mostly due to its low incidence rate, accounting for only 0.5-1% of all reported …

Although immune checkpoint inhibitors (ICIs) are increasingly used as second-line
treatments for urothelial cancer (UC), only a small proportion of patients respond. Therefore, …

Patient-derived tumor organoids (PDTOs) have become relevant pre-clinical models for
therapeutic modeling since they highly recapitulate patients' responses to treatment. …